Of Animal Eggs and Human Embryos
By Editors,
New York Times
| 09. 24. 2007
Stem cell research in the United States has been hobbled for years by severe and misguided restrictions on federal funding. But now a vexing additional problem is slowing even privately financed research. There are distressingly few women willing to donate their eggs for experiments at the frontiers of this promising science.
A respected team of stem cell researchers at Harvard spent nearly $100,000 over the course of a year advertising for egg donors. Hundreds of qualified women were interested enough to call but, after hearing what was entailed, not one was willing to donate eggs. Many were likely deterred by the time, effort and pain required - including daily hormone injections and minor surgery - to retrieve the eggs. And they were almost certainly discouraged by the meager compensation.
Although women can be paid thousands of dollars to donate eggs for fertility treatments, ethical guidelines and some state laws say they cannot be paid much for donating to research. These restrictions are meant to protect the women against exploitation, but they have created a dearth of egg donors for stem...
Related Articles
By Carissa Wong, New Scientist | 07.08.2026
Healthy lambs have been born via an experimental form of in vitro fertilisation (IVF) that coaxes highly immature eggs to become mature ones in the lab. This is the first time the approach has been demonstrated in a large animal...
By Maggie Astor, The New York Times | 06.23.2026
Every year, patients undergo millions of in vitro fertilization procedures worldwide. Only a minority result in a live birth.
In an effort to improve the odds, scientists have developed an array of “add-ons” that could in theory identify the most...
By Carl Zimmer and Catrin Einhorn, The New York Times | 06.25.2026
The Trump administration and a company that is promising to bring long-gone animals back from extinction announced a partnership on Thursday to preserve cells, tissue and DNA from threatened and endangered species.
The company, Colossal Biosciences, said its goal was...
By Julianna LeMieux, Genetic Engineering & Biotechnology News | 04.14.2026
Twenty years ago, Sven Bocklandt, PhD, sought to create a hypoallergenic cat. He had the genetic engineering chops to do it, but the embryology was beyond his capabilities. At a small animal genetic engineering conference, known as TARC (Transgenic Animal...